For Immediate Release
For more information contact:
Feinstein Kean Healthcare
Accelerated Cure Project Partners with Curbside.MD to Provide Patients and Physicians With Timely, Comprehensive Answers to Questions About Multiple Sclerosis
-- The Accelerated Cure Project for Multiple Sclerosis has partnered with Praxeon, Inc., a Boston-based life sciences company which has developed a patent pending search engine currently focused on supporting investigation of neurological diseases. The search engine, Curbside.MD, is an easy- to-use research tool for patients, researchers and physicians to keep up to date on the latest clinical trials, symptoms, treatments and research results. Access to Curbside.MD is now available from the Accelerated Cure Project website, www.acceleratedcure.org
The complexity and ambiguity of Multiple Sclerosis directly challenges a sense of patient empowerment, says Art Mellor, founder and CEO of Accelerated Cure Project. Patients are in need of a reliable and trusted source of medical information about MS and Curbside.MD fills that void. Its also a great forum for sharing critical information about this disease among physicians, researchers and patients with MS.
Curbside.MD utilizes Praxeon's patent-pending semantic fingerprinting technology. This technology uses a sophisticated model of medical terminology to extract the meaning and relationships of words within any unstructured text source. With Curbside.MD users can enter naturally phrased clinical questions to search evidence based material, making this an ideal resource for anyone who wants to learn more about the disease. The more details users enter, the more accurate the search results. Currently, Curbside.MD revolves primarily around neurological diseases and drugs. But content is being loaded from many other specialties in medicine.
We built Curbside.MD after realizing the difficulties physicians and patients have in finding evidence based answers to their clinical questions, says Nick Encina, President and COO of Praxeon. Physicians are daunted by the prospect of reading, retaining and synthesizing all new health care knowledge. And such a comprehensive understanding of a clinical area is rarely available at the time of greatest need, at the point of clinical care.
Generic, non-specialized search engines don't always bring back the best material. There are also many on-line textbooks and reviews available, but even these can be difficult to access, search and may be incomplete. Curbside.MD fills the void by allowing for naturally phrased clinical questions to draw from premier, evidence-based material.
Once a question is posed, Curbside.MD displays a results page. The results summary page provides a first glimpse into the search results. Curbside.MD has made finding answers easy by dividing the results into easy to navigate categories including best hits, visual diagnosis, quick consult, best evidence and clinical trials. To start a search, log on to http://www.acceleratedcure.org/msresources/curbside.php
About Praxeon, Inc.
Praxeon, Inc. is a life sciences startup founded in 2005 with over 50 years of collective experience in health care and life sciences. The organization is comprised of physicians, scientists, software developers and researchers. For more information about Praxeon call 617-848-2606, or visit www.praxeon.com
. For information on Curbside.MD visit www.curbside.md
About Accelerated Cure Project
Accelerated Cure Project for MS (ACP) is a nonprofit organization whose mission is to accelerate efforts toward a cure for multiple sclerosis (MS) by rapidly advancing research that determines its causes and mechanisms. We provide biomedical researchers with resources that catalyze open scientific collaboration and enable them to explore their novel research ideas rapidly and cost-efficiently. ACP’s strategic initiatives include the Multiple Sclerosis Discovery Forum and the ACP Repository, a large-scale collection of highly-characterized biosamples available to scientists at any organization conducting research that contributes to our mission. All results generated through analysis of Repository samples and data are contributed back to the ACP Repository Database, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. To date, ACP has enrolled almost 3,000 participants into the Repository through a network of 10 MS clinical centers across the United States. The samples provided by people with MS and related disorders have supported more than 60 research studies worldwide and generated more than 150 million returned data points.
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the US and two million individuals worldwide. The disorder occurs twice as often in women as in men. What causes MS is undetermined and no cure has yet been developed.